Witzig TE - Search Results

1

Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.

Hu G, Dasari S, Asmann YW, Greipp PT, Knudson RA, Benson HK, Li Y, Eckloff BW, Jen J, Link BK, Jiang L, Sidhu JS, Wellik LE, Witzig TE, Bennani NN, Cerhan JR, Boddicker RL, Feldman AL. Hu G, et al. Among authors: witzig te. Leukemia. 2018 Feb;32(2):565-569. doi: 10.1038/leu.2017.309. Epub 2017 Oct 13. Leukemia. 2018. PMID: 29026208 Free PMC article. No abstract available.

2

Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS.

Billadeau D, Greipp P, Ahmann G, Witzig T, Van Ness B. Billadeau D, et al. Curr Top Microbiol Immunol. 1995;194:9-16. doi: 10.1007/978-3-642-79275-5_2. Curr Top Microbiol Immunol. 1995. PMID: 7895525 No abstract available.

3

Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.

Westendorf JJ, Ahmann GJ, Greipp PR, Witzig TE, Lust JA, Jelinek DF. Westendorf JJ, et al. Among authors: witzig te. Leukemia. 1996 May;10(5):866-76. Leukemia. 1996. PMID: 8656685

4

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.

Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Rajkumar S, et al. Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943. Bone Marrow Transplant. 1999. PMID: 10482933

5

Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.

Ansell SM, Kurtin PJ, Stenson M, Habermann TM, Greipp PR, Therneau TM, Witzig TE. Ansell SM, et al. Among authors: witzig te. Leuk Lymphoma. 1999 Aug;34(5-6):529-37. doi: 10.3109/10428199909058480. Leuk Lymphoma. 1999. PMID: 10492076

6

Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphoma.

Yoong Y, Kurtin PJ, Allmer C, Geyer S, Habermann TM, Nagorney DM, Witzig TE. Yoong Y, et al. Among authors: witzig te. Leuk Lymphoma. 2001 Nov-Dec;42(6):1235-41. doi: 10.3109/10428190109097748. Leuk Lymphoma. 2001. PMID: 11911404

7

Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells.

Arendt BK, Velazquez-Dones A, Tschumper RC, Howell KG, Ansell SM, Witzig TE, Jelinek DF. Arendt BK, et al. Among authors: witzig te. Leukemia. 2002 Oct;16(10):2142-7. doi: 10.1038/sj.leu.2402714. Leukemia. 2002. PMID: 12357369

8

Prognostic value of angiogenesis in solitary bone plasmacytoma.

Kumar S, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Wellik L, Witzig TE, Gertz MA, Kyle RA, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: witzig te. Blood. 2003 Mar 1;101(5):1715-7. doi: 10.1182/blood-2002-08-2441. Epub 2002 Oct 17. Blood. 2003. PMID: 12393501 Free article.

9

Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.

Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers TA, Folsom AR. Cerhan JR, et al. Among authors: witzig te. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1466-71. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433728

10

Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.

Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM. Cerhan JR, et al. Among authors: witzig te. Int J Cancer. 2003 Sep 20;106(5):784-8. doi: 10.1002/ijc.11311. Int J Cancer. 2003. PMID: 12866040 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

643 results

Search Page

Filters